These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17010550)
21. [Pseudomonas stutzeri prosthetic joint infection: a therapeutic challenge associated with multiple severe complications]. Alonso Menchén D; Barbero Allende JM; Balsa Vázquez J; Jacob García-Asenjo CI; Hernández García G; Font González R Rev Esp Quimioter; 2020 Jun; 33(3):218-220. PubMed ID: 32281776 [No Abstract] [Full Text] [Related]
22. Nosocomially acquired Pseudomonas stutzeri brain abscess in a child: case report and review. Yee-Guardino S; Danziger-Isakov L; Knouse M; Bingaman W; Sabella C; Goldfarb J Infect Control Hosp Epidemiol; 2006 Jun; 27(6):630-2. PubMed ID: 16755486 [TBL] [Abstract][Full Text] [Related]
23. [Pseudomonas and acute external otitis. Results of a microbiological study in patients without previous antibiotic treatment]. Pino Rivero V; Pantoja Hernández CG; González Palomino G; Mora Santos ME; Pardo Romero G; Blasco Huelva A An Otorrinolaringol Ibero Am; 2007; 34(1):45-51. PubMed ID: 17405458 [TBL] [Abstract][Full Text] [Related]
24. Pseudomonas stutzeri pneumonia in an HIV seropositive patient. Loyse A; Storring RA; Melzer M J Infect; 2006 Jul; 53(1):75-6. PubMed ID: 16274743 [No Abstract] [Full Text] [Related]
25. Treatment protocol for open AO/OTA type C3 pilon fractures with segmental bone loss. Gardner MJ; Mehta S; Barei DP; Nork SE J Orthop Trauma; 2008 Aug; 22(7):451-7. PubMed ID: 18670284 [TBL] [Abstract][Full Text] [Related]
26. Ceftazidime activity in experimental pseudomonas pyelonephritis in rats. Ritzerfeld W J Antimicrob Chemother; 1981 Sep; 8 Suppl B():257-9. PubMed ID: 19802995 [TBL] [Abstract][Full Text] [Related]
27. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system]. Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514 [TBL] [Abstract][Full Text] [Related]
28. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis. Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686 [TBL] [Abstract][Full Text] [Related]
29. Orbital cellulitis and endophthalmitis in pseudomonas septicemia. Luemsamran P; Pornpanich K; Vangveeravong S; Mekanandha P Orbit; 2008; 27(6):455-7. PubMed ID: 19085303 [TBL] [Abstract][Full Text] [Related]
30. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome. Yagmur R; Esen F Crit Care; 2006; 10(6):428. PubMed ID: 17214907 [No Abstract] [Full Text] [Related]
31. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
39. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A; J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995 [TBL] [Abstract][Full Text] [Related]
40. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia. Croisier D; Martha B; Piroth L; Chavanet P Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]